Fortrea

About Fortrea

Fortrea is a global Contract Research Organization (CRO) focused on advancing clinical trials and drug development. They provide comprehensive Phase I through IV study management, clinical pharmacology, and market access solutions to biopharma and MedTech companies worldwide. With over 30 years of experience, Fortrea aims to modernize clinical research, accelerate medical innovation, and keep patients at the heart of their decisions.

Products & Services

Clinical Solutions:Includes clinical development, clinical trial management, data management, diversity & inclusion in trials, mobile clinical services, and digital health solutions.

Clinical Pharmacology Services:Offers Phase I units and in-clinic cGMP pharmacies for early-phase research.

Consulting:Provides services in market access, health economics and outcomes research (HEOR), patient-centered endpoints, product development, and regulatory strategy.

Functional Service Provider (FSP):Delivers specialized services in clinical operations, data management, biostatistics, statistical programming, safety services, and medical writing.

MedTech:Supports development of medical devices and diagnostics.

RWE & Post-Approval Studies:Focuses on real-world evidence and post-approval research.

Safety Services & Medical Writing:Ensures safety monitoring and documentation for clinical trials.

Site Connections:Offers site advisory boards, technology, and support services to enhance trial site partnerships.

Therapeutics:Covers therapeutic areas such as oncology, cardiovascular, cell and gene therapies, diabetes, dermatology, hematology, infectious diseases, neuroscience, and rare diseases.

Specialties

Clinical Trial Management Clinical Pharmacology Market Access Consulting Regulatory Strategy Real-World Evidence (RWE) Pharmacovigilance Cell and Gene Therapies Oncology Data Management Digital Health Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Senior Secured Notes Offering T: - FT: Senior Secured Notes Offering	A: 570000000 MR: - FA: $570 million FAN: 570000000	D: 2023-06-12 FD: 2023-06-12	-

Senior Secured Notes Offering Latest

2023-06-12

$570.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jan Skoumal

Therapeutic Area Delivery Head, Hematology/Oncology

D

Diana Aguirre

Senior Medical Director

M

Maixing Ai

Senior Medical Director

P

Peter Alfinito

Executive Director, Strategic Delivery and Growth

V

Victor Angélico

Senior Medical Director

D

Dana Annunziato

Senior Director, Strategy Delivery & Growth

View 26 more team members with Pro

Unlock Full Team Directory

Recent News

Fortrea Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

About Fortrea

Products & Services

Specialties

Funding History

Growth Metrics

Team & Leadership

Recent News

Fortrea Announces New Product Launch

Leadership Team Expands with Industry Veteran

Company Recognized as Industry Leader

Key Competitors

Competitor Alpha

Competitor Beta

Competitor Gamma

Competitor Delta

Company Details

Similar Companies

Technology Stack